Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Exchange Rate Effect (2016 - 2026)

Sunshine Biopharma filings provide 11 years of Exchange Rate Effect readings, the most recent being $758585.0 for Q4 2025.

  • On a quarterly basis, Exchange Rate Effect rose 219.41% to $758585.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $855750.0, a 182.02% increase, with the full-year FY2025 number at $855750.0, up 182.02% from a year prior.
  • Exchange Rate Effect hit $758585.0 in Q4 2025 for Sunshine Biopharma, up from -$228322.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $772282.0 in Q3 2024 to a low of -$1.3 million in Q2 2024.
  • Median Exchange Rate Effect over the past 5 years was -$1535.0 (2021), compared with a mean of -$15086.9.
  • The widest YoY moves for Exchange Rate Effect: up 2048.63% in 2024, down 14684477.78% in 2024.
  • Sunshine Biopharma's Exchange Rate Effect stood at -$20268.0 in 2021, then crashed by 185.37% to -$57839.0 in 2022, then plummeted by 70.52% to -$98626.0 in 2023, then plummeted by 544.15% to -$635298.0 in 2024, then soared by 219.41% to $758585.0 in 2025.
  • The last three reported values for Exchange Rate Effect were $758585.0 (Q4 2025), -$228322.0 (Q3 2025), and $335684.0 (Q2 2025) per Business Quant data.